Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF – Get Free Report) is expected to be releasing its resultson Tuesday, April 21st. Analysts expect Beiersdorf Aktiengesellschaft to post earnings of $2.16 per share and revenue of $5.4764 billion for the quarter.
Beiersdorf Aktiengesellschaft Price Performance
OTCMKTS:BDRFF opened at $86.10 on Tuesday. The firm has a 50-day moving average of $99.76 and a 200-day moving average of $105.15. Beiersdorf Aktiengesellschaft has a one year low of $83.94 and a one year high of $145.88.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on BDRFF. Royal Bank Of Canada downgraded shares of Beiersdorf Aktiengesellschaft from a “sector perform” rating to an “underperform” rating in a research report on Tuesday, March 10th. Morgan Stanley downgraded shares of Beiersdorf Aktiengesellschaft from an “equal weight” rating to an “underweight” rating in a research report on Monday, March 16th. JPMorgan Chase & Co. reissued a “neutral” rating on shares of Beiersdorf Aktiengesellschaft in a research report on Wednesday, March 18th. Berenberg Bank reissued a “hold” rating on shares of Beiersdorf Aktiengesellschaft in a research report on Monday, March 23rd. Finally, UBS Group raised shares of Beiersdorf Aktiengesellschaft from a “sell” rating to a “neutral” rating in a research report on Tuesday, March 31st. Four investment analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Reduce”.
Beiersdorf Aktiengesellschaft Company Profile
Beiersdorf Aktiengesellschaft is a global consumer goods company headquartered in Hamburg, Germany, with a history dating back to its founding in 1882 by pharmacist Paul C. Beiersdorf. The company is best known for its skincare brands, including NIVEA, Eucerin, La Prairie and Labello, as well as its tesa division, which produces self-adhesive products and industrial tapes. Over its long history, Beiersdorf has built a reputation for innovation in dermatological research and product development, introducing pioneering formulations that span mass-market and premium segments.
The company’s operations are organized into two main business divisions.
Further Reading
Receive News & Ratings for Beiersdorf Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beiersdorf Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
